Business News
Gerresheimer AG: 2007 another record year in terms of sales and earnings
Monday 04. February 2008 - According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of 957.7m, up by 48.1%; the adjusted Group EBITDA margin reached 19%.
“This gratifying development completely and fully confirms our strategy,” says Dr. Axel Herberg, Chief Executive Officer of Gerresheimer AG: “With the help of acquisitions we have successfully expanded our global presence and set the course for further growth.”
Rapid expansion of operations in the South American pharma and life science market
Shortly after taking over EDP S.A. with production in Spain and South America, this international company based in Düsseldorf, Germany, now announces the acquisition of ALLPLAS Embalagens Ltda. (São Paulo), which is the market leader for pharmaceutical plastic packaging in Brazil. This marks the successful completion of another important step in the global expansion of the Gerresheimer Group.
For Gerresheimers Plastic Systems Division, finalisation of the latest contract puts the cap on a dramatic move into South America. It was only at the end of December last year that Gerresheimer, as reported, acquired EDP, the Spanish market leader for pharmaceutical PET bottles, thereby also establishing a foothold in South America for the first time. With Allplas, which operates two production plants in São Paulo, Gerresheimer now already has three strategically important bases in the region.
The Brazilian company is a well-established supplier to the pharmaceutical industry, with innovative products and a reputation for high quality. Allplas manufactures high-calibre vials and application and closure systems for liquid formulations and solid dosages (for example eye drops and tablets), which ideally complement – and can be combined with – Gerresheimers product range. The Groups existing product portfolio in the field of plastic packaging, which has so far been marketed primarily in Europe, will as a result increasingly find its way into the South American pharmaceutical markets.
Allplas currently achieves annual sales equivalent to around 16m. The EBITDA margin is 16%, which will be continuously improved in the years ahead. Integration in the Gerresheimer Group is to be completed by mid-2008. Like EDP, Allplas will become part of Gerresheimer Plastic Packaging, which specialises in pharmaceutical primary packaging and application systems under leading trade¬marks such as Duma, Dudek TM and EDP TM. Together with the two acquisitions, Gerresheimers plastic operations achieve a total annual sales volume of around 350m, of which around 100m is attribut¬able to the plastic packaging segment.